Results 161 to 170 of about 41,795 (272)
Abstract Background Ovarian cancer remains a formidable therapeutic challenge due to late diagnosis, high recurrence rates, and limited treatment options. Mesothelin (MSLN) is highly expressed in ovarian cancer, making it a promising target for immunotherapy.
Yiyang Shan +7 more
wiley +1 more source
[Probable neutropenia secondary to treatment with rifampicin]. [PDF]
España-Marí G +4 more
europepmc +1 more source
Abstract Objective To explore the efficacy and safety of surufatinib in combination with anti‐PD‐1/PD‐L1 antibodies (with or without chemotherapy) in patients with advanced BTC after failure of first‐line treatment. Methods 24 patients with advanced BTC who failed first‐line treatment were admitted to our centre from March 2023 to August 2024 and ...
Xinni Chen +7 more
wiley +1 more source
Ulceration in Dermatophyte Infection in Methotrexate Toxicity: Hitherto Unkown. [PDF]
Das P +5 more
europepmc +1 more source
Experience of the University of Pittsburgh, Pittsburgh, Pennsylvnaia, USA [PDF]
Carroll, PB +4 more
core
Frontiers in the Management of Orthopaedic Periprosthetic Joint Infection
ABSTRACT Periprosthetic joint infection (PJI) is a devastating complication of total joint arthroplasty (TJA), one of the most frequently performed surgical procedures worldwide. Management of acute PJI commonly involves debridement, antibiotics, and implant retention (DAIR), though failure rates remain high due to antibiotic‐tolerant biofilms. Chronic
Michael F. Shannon +9 more
wiley +1 more source
Efficacy and safety of plasma exchange for crescentic and mixed classes of ANCA-associated glomerulonephritis with renal insufficiency. [PDF]
Yao Z, Wang P, Gao Y, Zhang P.
europepmc +1 more source
Abstract Objectives Methotrexate (MTX) is frequently prescribed in paediatric inflammatory bowel disease (IBD), with routine laboratory monitoring to detect adverse events (AEs), such as hepatotoxicity and myelotoxicity. However, data on the incidence and predictors of these AEs remain limited.
Eva Vermeer +7 more
wiley +1 more source
Long-Term Therapeutic Outcomes with Cladribine in Patients with Xanthoma Disseminatum. [PDF]
Sharma A +7 more
europepmc +1 more source

